BCS Barclays PLC
Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK; Barclays UK Corporate Bank; Barclays Private Bank and Wealth Management; Barclays Investment Bank; and Barclays US Consumer Bank segments. It offers financial services, such as current accounts, savings accounts, mortgages and unsecured lending, such as credit cards and loans retail banking, wholesale banking, investment banking, wealth management, and investment management services, as well as lending products. In addition, the company engages in securities dealing activities and issuing of credit cards. The company was formerly known as Barclays Bank public limited company and changed its name to Barclays PLC in January 1985. Barclays PLC was founded in 1690 and is headquartered in London, the United Kingdom.…
Industry Peers
Banks - DiversifiedKey Statistics
About Barclays (NYSE: BCS)
›
Barclays (NYSE: BCS) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Banks - Diversified industry, part of the Financial Services sector, and reports about 93,000 employees.
The shares were at 21.32 USD on 19 November 2026, up 2.9% over 52 weeks. Its 52-week range is 19.29 USD to 28.07 USD: the price is 24.0% below the high and 10.5% above the low.
At a market capitalisation of 70.78B USD, it trades at 8.0 times trailing earnings and 6.8 times forward earnings. The median trailing P/E of its 20 largest Banks - Diversified peers is 13.1, a discount of 39% for BCS. It pays a dividend yielding 2.85% (it pays out 23% of its earnings), against a median of 2.48% among the dividend payers in that peer group.
Barclays reports return on equity of 9.2%, an operating margin of 37.0% and revenue up 4.9% year over year.
It holds more cash than debt, a net cash position of 5.70B GBP. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Buy; their mean price target of 28.94 USD is 35.7% above the current price. The next earnings report is expected on 9 February 2027.